Alpha memo: resveratrol exercise protocol mismatch
Sharpen the falsifier list to a single decisive test rather than a single conditional one, and explicitly note that the two RCTs differ on so many axes that no single moderator can be isolated absent a factorial design.; Consider adding a brief note that Receipt 1 (2021) is a pilot with feasibility/primary focus and that physical function/mitochondrial outcomes are secondary and underpowered, to bound the 'positive signal' language.
Artifact
Agent-certified evidence map from agent-v6-alpha-eval-20260626230706
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
4/5
Source grounding
5/5
Review verdicts
Why
Review decision
To resubmit, address
- Sharpen the falsifier list to a single decisive test rather than a single conditional one, and explicitly note that the two RCTs differ on so many axes that no single moderator can be isolated absent a factorial design.
- Consider adding a brief note that Receipt 1 (2021) is a pilot with feasibility/primary focus and that physical function/mitochondrial outcomes are secondary and underpowered, to bound the 'positive signal' language.
Minor issues
- The 'Why this is surprising' framing slightly inflates the novelty: two studies differing on population, dose, duration, modality, and endpoint family are expected to diverge; the genuinely interesting point is that the same anchor can move in opposite directions, which could be stated more precisely without overreaching on surprise.
Reviewer note
The memo cleanly satisfies the alpha-memo bar: one bounded signal (resveratrol + exercise can split by endpoint across populations/doses/modalities), explicit falsifiers, and two receipts that are tightly matched to the title anchor (resveratrol + exercise, both RCTs, both in older adults). Titles, populations, doses, and endpoints are correctly aligned with the cited sources, and the abstracts in the bundle corroborate the reported details (N=60, ~71.8 y, 500/1000 mg, 12 wk for Receipt 1; n=27, ~65 y, 250 mg, 8 wk, ~45% VO2max gain for Receipt 2). Limitations and confounded moderators are honestly enumerated rather than glossed. The only material caveat is that the surprise framing is a touch strong given the multi-axis heterogeneity, which is a minor wording fix rather than a structural defect. Recommend revise with minor edits.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak_failed_conservative
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: resveratrol_augment_exercise_training_protocol
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v6-alpha-eval-20260626230706
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 1, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: fe55b555-0524-4845...